Mesa Laboratories, Inc.
MLAB
$126.18
$3.853.15%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -249.44M | -245.65M | -250.31M | -254.25M | 948.00K |
| Total Depreciation and Amortization | 23.33M | 26.88M | 28.91M | 31.57M | 33.64M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 267.37M | 256.78M | 259.27M | 260.83M | 9.75M |
| Change in Net Operating Assets | 5.78M | 2.11M | 6.76M | 5.97M | -576.00K |
| Cash from Operations | 47.03M | 40.12M | 44.63M | 44.13M | 43.77M |
| Capital Expenditure | -4.03M | -4.34M | -3.19M | -2.57M | -3.06M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | 961.00K | -78.74M | -78.74M | -78.74M | -79.70M |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -3.07M | -83.08M | -81.93M | -81.31M | -82.76M |
| Total Debt Issued | 73.47M | 144.47M | 144.47M | 71.00M | 71.00M |
| Total Debt Repaid | -109.37M | -108.63M | -106.19M | -33.50M | -28.00M |
| Issuance of Common Stock | 0.00 | 0.00 | 0.00 | 0.00 | 2.47M |
| Repurchase of Common Stock | -2.00K | -2.00K | -2.00K | -2.00K | -10.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -3.46M | -3.46M | -3.45M | -3.45M | -3.44M |
| Other Financing Activities | -1.88M | -2.19M | -1.58M | -1.22M | -648.00K |
| Cash from Financing | -41.25M | 30.20M | 33.25M | 32.84M | 41.38M |
| Foreign Exchange rate Adjustments | 21.00K | 1.48M | 150.00K | -359.00K | -265.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 2.73M | -11.28M | -3.90M | -4.70M | 2.12M |
